Ophthalmology - Eye Health Academy

Episodes 1-16 of 69

KOL KO™: Oculoplastics Edition | Eyeing Up the Best in TED Management
KOL KO™: Oculoplastics Edition | Eyeing Up the Best in TED Management
CME/CE Live Broadcast
KOL KO™: Oculoplastics Edition | Eyeing Up the Best in TED Management
October 17, 2025
11:50 AM - 12:50 PM ET
1.00 credit Learn more
CME/CE Meeting
KOL KO™: Oculoplastics Edition | Eyeing Up the Best in TED Management
October 17, 2025
Orlando, Florida
1.00 credit Learn more
TKIs and the Future of Care
TKIs and the Future of Care
Clinical Minute Retina
TKIs and the Future of Care
- Maria H. Berrocal, MD
- Dilsher S. Dhoot, MD
Comparing Anti-VEGF Therapies: Real-World Insights on Efficacy, Safety, and Dosing
Comparing Anti-VEGF Therapies: Real-World Insights on Efficacy, Safety, and Dosing
Eye on Ocular Health
Comparing Anti-VEGF Therapies: Real-World Insights on Efficacy, Safety, and Dosing
- Charles Turck, PharmD, BCPS, BCCCP
- Michael Javaheri, MD
Decoding Variable Responses to Anti-VEGF Therapy in AMD and DME Care
Decoding Variable Responses to Anti-VEGF Therapy in AMD and DME Care
Eye on Ocular Health
Decoding Variable Responses to Anti-VEGF Therapy in AMD and DME Care
- Charles Turck, PharmD, BCPS, BCCCP
- Joseph M. Coney, MD
Optimizing Anti-VEGF Sequencing: Strategies to Reduce Burden and Personalize Care
Optimizing Anti-VEGF Sequencing: Strategies to Reduce Burden and Personalize Care
Eye on Ocular Health
Optimizing Anti-VEGF Sequencing: Strategies to Reduce Burden and Personalize Care
- Brian P. McDonough, MD, FAAFP
- Mitchell J. Goff
Risk of RVO in Type 2 Diabetes: GLP-1 Receptor Agonists Versus DPP-4 Inhibitors
Risk of RVO in Type 2 Diabetes: GLP-1 Receptor Agonists Versus DPP-4 Inhibitors
Eye on Ocular Health
Risk of RVO in Type 2 Diabetes: GLP-1 Receptor Agonists Versus DPP-4 Inhibitors
- Marlene Mimi Maeusli, PhD.
Late-Presenting IOFBs: How To Detect Them—and Why They Are Missed
Late-Presenting IOFBs: How To Detect Them—and Why They Are Missed
Clinical Minute Retina
Late-Presenting IOFBs: How To Detect Them—and Why They Are Missed
- Maria H. Berrocal, MD
- Nimesh Patel, MD
AI Chatbots vs. Ophthalmology Trainees for Diagnosing and Triaging Common Conditions
AI Chatbots vs. Ophthalmology Trainees for Diagnosing and Triaging Common Conditions
Clinical Minute Retina
AI Chatbots vs. Ophthalmology Trainees for Diagnosing and Triaging Common Conditions
- Maria H. Berrocal, MD
- Sruthi Arepalli, MD
OCT Biomarkers as Predictors of Treatment Response in RVO-Related Macular Edema
OCT Biomarkers as Predictors of Treatment Response in RVO-Related Macular Edema
Eye on Ocular Health
OCT Biomarkers as Predictors of Treatment Response in RVO-Related Macular Edema
- Marlene Mimi Maeusli, PhD.
Myopia Control in Europe: The Case for Upfront Investment in Childhood
Myopia Control in Europe: The Case for Upfront Investment in Childhood
Eye on Ocular Health
Myopia Control in Europe: The Case for Upfront Investment in Childhood
Tackling the Myopia Epidemic: Causes, Consequences, and Opportunities for Prevention
Tackling the Myopia Epidemic: Causes, Consequences, and Opportunities for Prevention
Eye on Ocular Health
Tackling the Myopia Epidemic: Causes, Consequences, and Opportunities for Prevention
- Ryan Quigley
- Michael Twa , MD
- David Berntsen, MD
Advancing Myopia Detection and Treatment: A Look at Novel Innovations
Advancing Myopia Detection and Treatment: A Look at Novel Innovations
Eye on Ocular Health
Advancing Myopia Detection and Treatment: A Look at Novel Innovations
- Ryan Quigley
- Michael D. Twa, OD, PhD, FAAO
- David A. Berntsen, OD, PhD, FAAO
Switch Case: Potential Response to Ang-2 in Wet AMD
Switch Case: Potential Response to Ang-2 in Wet AMD
AMD/DME Case Files: Real-World Patient Profiles
Switch Case: Potential Response to Ang-2 in Wet AMD
- Ash Abbey, MD
Switch Case: Faricimab to High-dose Aflibercept
Switch Case: Faricimab to High-dose Aflibercept
AMD/DME Case Files: Real-World Patient Profiles
Switch Case: Faricimab to High-dose Aflibercept
- Ash Abbey, MD
Real-World Treatment-Naïve Case: Bilateral Advanced DME Treated with Two Different Agents
Real-World Treatment-Naïve Case: Bilateral Advanced DME Treated with Two Different Agents
AMD/DME Case Files: Real-World Patient Profiles
Real-World Treatment-Naïve Case: Bilateral Advanced DME Treated with Two Different Agents
- Scott Walter, MD, MSc

Prev
1
2
3
4
5
Next

1/5